Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection
NCT ID: NCT05143372
Last Updated: 2024-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-11-09
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19
NCT05188482
Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators
NCT04749121
Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit
NCT04355481
Impact of Teeth Brushing in Ventilated COVID-19 Patients.
NCT05575050
Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis
NCT00122057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SaO2 (oxygen status)
Measurment 4 times per day, ABA (acid-bases analyses)
Vibrolung
Vibroacoustic respiratory therapy
PaO2/FiO2 (respiratory index)
Measurment 4 times per day, ABA (acid-bases analyses)
Vibrolung
Vibroacoustic respiratory therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibrolung
Vibroacoustic respiratory therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* P/F less 300 torr
* COVID-19 Virus Infection
Exclusion Criteria
* acute stroke
* acute coronary syndrome
* DVT
* implanted pacemaker
* rib fracture
* infection on chest
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astana Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aidos Konkayev
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NATIONAL CENTER Scientific Center of Traumatology and Orthopedics named after Academician Batpenov N.D.
Astana, , Kazakhstan
Multidisciplinary city hospital No. 3 of Nursultan
Astana, , Kazakhstan
Multidisciplinary Infectious Diseases Hospital of Nursultan
Astana, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Konkayev A, Bekniyazova A. Vibroacoustic therapy in the treatment of patients with COVID-19 complicated by respiratory failure: a pilot randomized controlled trial. Front Med (Lausanne). 2023 Dec 14;10:1225384. doi: 10.3389/fmed.2023.1225384. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
СТЛ-000215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.